منابع مشابه
Pharmacogenomics in osteoporosis: Steps toward personalized medicine
Osteoporosis is a complicated and preventable disease with major morbidity complications that affects millions of people. In the last 15 years, there have been numerous studies and research in the new fields of pharmacogenetics and pharmacogenomics related to osteoporosis. Numerous "candidate genes" have been identified and have been found to be associated with osteoporosis as well as the treat...
متن کاملProgress toward personalized medicine for glaucoma.
How will you respond when a patient asks, "Doctor, what can I do to prevent myself from going blind from glaucoma like mom?". There is optimism that genetic profiling will help target patients to individualized treatments based on validated disease risk alleles, validated pharmacogenetic markers and behavioral modification. Personalized medicine will become a reality through identification of d...
متن کاملGreat challenges in molecular medicine: toward personalized medicine
GENE HUNTING, SIGNALING NETWORK, AND MOLECULAR MEDICINE In the 20th century, most researchers investigated WNT signaling in cell and developmental biology by using model animals, such as Drosophila, Xenopus, and mouse. However, I was confident that WNT signaling should be investigated for clinical application by using human samples or cell lines. In 1998, I, together with post-doctoral fellows,...
متن کاملContemporary approaches to gene discovery: progress toward personalized medicine?
It is broadly recognized that cardiovascular disease has a familial basis; however, progress in identifying the causative genes has been slow. The goal of identifying disease genes or those genes influencing cardiovascular risk factor phenotypes is at the heart of personalized medicine, giving rise to the hope that such knowledge will identify new therapeutic targets, help identify individuals ...
متن کاملPharmacogenomics of sickle cell disease: steps toward personalized medicine
Sickle cell disease (SCD) is a monogenetic disease but has a wide range of phenotypic expressions. Some of these differences in phenotype can be explained by genetic polymorphisms in the human globin gene. These polymorphisms can result in different responses to typical treatment, sometimes leading to inadequate therapeutics. Research is revealing more polymorphisms, and therefore, new targets ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Sports Medicine
سال: 2013
ISSN: 0112-1642,1179-2035
DOI: 10.1007/s40279-013-0018-0